The detection of pulmonary nodules is common. In populations undergoing CTscreening and at high risk of lung cancer, nodules are detected in 20–50% of individuals, depending on the size of the cut-off point for reporting a nodule.
Dyspnoea is described as difficult or laboured breathing and is a frequent symptom in advanced cancer patients, with the highest prevalence in lung cancer. Dyspnoea has been demonstrated to be one of the most distressing...
Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer
This report from the 2nd ESMO Consensus Conference on Lung Cancer complements existing guidelines and provides recommendations by international experts on guidance on tissue handling...
2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease
This report from the 2nd ESMO Consensus Conference on Lung Cancer covers all patients (regardless of NSCLC mutational status): chemotherapy in asymptomatic patients, anti-angiogenic treatment...
The guideline covers all aspects of the management of patients with small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), reflecting the most recent evidence on diagnostic and staging investigations...
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
These updated guidelines on early and locally advanced non-small-cell lung cancer focus on treatment recommendations including follow-up and survivorship.
Small-cell lung cancer (SCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
This latest version of the ESMO Clinical Practice Guideline on SCLC includes chapters on incidence and epidemiology, diagnosis and pathology/molecular biology, staging and risk assessment
Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
The ESMO Clinical Practice Guidelines (CPG) are intended to provide the user with a set of recommendations for the best standards of cancer care, based on the findings of evidence-based medicine.
British Thoracic Society guideline for advanced diagnostic and therapeutic flexible bronchoscopy in adults
Advanced diagnostic and therapeutic procedures in adults using a flexible bronchoscope are included in the guideline.
This guideline covers diagnosing and managing non-small-cell and small-cell lung cancers in children, young people and adults.